Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosine A1 receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A2a receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A3 receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | follicle stimulating hormone receptor | adenosine A2a receptor | 412 aa | 336 aa | 22.3 % |
Brugia malayi | hypothetical protein | adenosine A1 receptor | 326 aa | 305 aa | 21.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | 5'partial|cyclin dependent kinase 1 | 0.0096 | 0.3583 | 0.3501 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0096 | 0.3583 | 0.3501 |
Echinococcus granulosus | cyclin dependent kinase | 0.0096 | 0.3583 | 0.3501 |
Giardia lamblia | Kinase, CMGC CDK | 0.0096 | 0.3583 | 0.3501 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0037 | 0.0126 | 0.0126 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0096 | 0.3583 | 0.3583 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0206 | 1 | 1 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0096 | 0.3583 | 0.2344 |
Trichomonas vaginalis | cyclins, putative | 0.0062 | 0.1619 | 0.1619 |
Echinococcus multilocularis | cyclin B | 0.0062 | 0.1619 | 0.1511 |
Brugia malayi | cell division control protein 2 homolog | 0.0096 | 0.3583 | 0.2344 |
Entamoeba histolytica | cyclin, putative | 0.0062 | 0.1619 | 0.1511 |
Giardia lamblia | Kinase, CMGC GSK | 0.0206 | 1 | 1 |
Trichomonas vaginalis | cyclin B3, putative | 0.0037 | 0.0126 | 0.0126 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0096 | 0.3583 | 0.2344 |
Trypanosoma brucei | cdc2-related kinase 3 | 0.0096 | 0.3583 | 0.2344 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0206 | 1 | 1 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0206 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0206 | 1 | 1 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0206 | 1 | 1 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0206 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0093 | 0.341 | 0.2137 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0096 | 0.3583 | 0.2344 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0151 | 0.6813 | 0.6198 |
Plasmodium falciparum | protein kinase 5 | 0.0096 | 0.3583 | 0.3501 |
Giardia lamblia | Kinase, CMGC GSK | 0.0206 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0206 | 1 | 1 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0206 | 1 | 1 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.0151 | 0.6813 | 0.6772 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.0096 | 0.3583 | 0.2344 |
Trichomonas vaginalis | cyclins, putative | 0.0062 | 0.1619 | 0.1619 |
Trichomonas vaginalis | cyclin B, putative | 0.0037 | 0.0126 | 0.0126 |
Entamoeba histolytica | protein kinase, putative | 0.0206 | 1 | 1 |
Trichomonas vaginalis | cyclin B, putative | 0.0062 | 0.1619 | 0.1619 |
Echinococcus granulosus | protein kinase shaggy | 0.0206 | 1 | 1 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0206 | 1 | 1 |
Echinococcus multilocularis | G2:mitotic specific cyclin B3 | 0.0151 | 0.6813 | 0.6772 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0096 | 0.3583 | 0.2344 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0096 | 0.3583 | 0.2344 |
Trypanosoma brucei | protein kinase, putative | 0.0206 | 1 | 1 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0096 | 0.3583 | 0.3501 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0096 | 0.3583 | 0.3583 |
Trichomonas vaginalis | cyclin A, putative | 0.0062 | 0.1619 | 0.1619 |
Trichomonas vaginalis | cyclin B, putative | 0.0062 | 0.1619 | 0.1619 |
Echinococcus multilocularis | cyclin dependent kinase | 0.0096 | 0.3583 | 0.3501 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0206 | 1 | 1 |
Leishmania major | cell division protein kinase 2,cdc2-related kinase | 0.0096 | 0.3583 | 0.2344 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0096 | 0.3583 | 0.3583 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0096 | 0.3583 | 0.3501 |
Trichomonas vaginalis | cyclin B, putative | 0.0062 | 0.1619 | 0.1619 |
Giardia lamblia | G2/mitotic-specific cyclin B | 0.0062 | 0.1619 | 0.1511 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.0151 | 0.6813 | 0.6198 |
Onchocerca volvulus | 0.0206 | 1 | 1 | |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0096 | 0.3583 | 0.3501 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0096 | 0.3583 | 0.3501 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0206 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0096 | 0.3583 | 0.2344 |
Schistosoma mansoni | cyclin B | 0.0062 | 0.1619 | 0.1511 |
Schistosoma mansoni | cyclin B3 | 0.0151 | 0.6813 | 0.6772 |
Echinococcus multilocularis | protein kinase shaggy | 0.0206 | 1 | 1 |
Trichomonas vaginalis | cyclin D, putative | 0.0037 | 0.0126 | 0.0126 |
Trichomonas vaginalis | cyclin B, putative | 0.0062 | 0.1619 | 0.1619 |
Trichomonas vaginalis | cyclins, putative | 0.0062 | 0.1619 | 0.1619 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0096 | 0.3583 | 0.2344 |
Trichomonas vaginalis | cyclins, putative | 0.0062 | 0.1619 | 0.1619 |
Echinococcus granulosus | cyclin dependent kinase 5 | 0.0096 | 0.3583 | 0.3501 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0206 | 1 | 1 |
Echinococcus granulosus | cyclin dependent kinase 1 | 0.0096 | 0.3583 | 0.3501 |
Leishmania major | cell division related protein kinase 2,cdc2-related kinase | 0.0096 | 0.3583 | 0.2344 |
Trichomonas vaginalis | cyclins, putative | 0.0037 | 0.0126 | 0.0126 |
Echinococcus multilocularis | cyclin dependent kinase 5 | 0.0096 | 0.3583 | 0.3501 |
Trypanosoma brucei | cdc2-related kinase 1 | 0.0096 | 0.3583 | 0.2344 |
Echinococcus granulosus | cyclin B | 0.0062 | 0.1619 | 0.1511 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0096 | 0.3583 | 0.3501 |
Trichomonas vaginalis | cyclin D, putative | 0.0037 | 0.0126 | 0.0126 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0206 | 1 | 1 |
Giardia lamblia | Kinase, CMGC CDK | 0.0096 | 0.3583 | 0.3501 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0206 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 5.4 nM | Displacement of [3H]NECA from human recombinant adenosine A3 receptor expressed in CHO cells | ChEMBL. | 17309246 |
Ki (binding) | = 5.4 nM | Displacement of [3H]NECA from human recombinant adenosine A3 receptor expressed in CHO cells | ChEMBL. | 17309246 |
Ki (binding) | = 95 nM | Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells | ChEMBL. | 17309246 |
Ki (binding) | = 95 nM | Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells | ChEMBL. | 17309246 |
Ki (binding) | = 758 nM | Displacement of [3H]NECA from human recombinant adenosine A2A receptor expressed in CHO cells | ChEMBL. | 17309246 |
Ki (binding) | = 758 nM | Displacement of [3H]NECA from human recombinant adenosine A2A receptor expressed in CHO cells | ChEMBL. | 17309246 |
Ratio Ki (binding) | = 18 | Selectivity for human adenosine A3 receptor over human adenosine A1 receptor | ChEMBL. | 17309246 |
Ratio Ki (binding) | = 140 | Selectivity for human adenosine A3 receptor over human adenosine A2A receptor | ChEMBL. | 17309246 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.